Table of Contents 1 Study Coverage 1.1 Psoriatic Arthritis Therapeutics Drug Product 1.2 Market Segments 1.3 Key Manufacturers Covered 1.4 Market by Type 1.4.1 Global Psoriatic Arthritis Therapeutics Drug Market Size Growth Rate by Product 1.4.2 NF Inhibitors 1.4.3 Interleukin Inhibitors 1.4.4 PDE4 Inhibitors 1.4.5 Others 1.5 Market by End User 1.5.1 Global Psoriatic Arthritis Therapeutics Drug Market Size Growth Rate by End User 1.5.2 Hospital Pharmacies 1.5.3 Retail Pharmacies 1.5.4 Online Pharmacies 1.6 Study Objectives 1.7 Years Considered 2 Executive Summary 2.1 Global Psoriatic Arthritis Therapeutics Drug Market Size 2.1.1 Global Psoriatic Arthritis Therapeutics Drug Revenue 2014-2025 2.1.2 Global Psoriatic Arthritis Therapeutics Drug Sales 2014-2025 2.2 Psoriatic Arthritis Therapeutics Drug Growth Rate by Regions 2.2.1 Global Psoriatic Arthritis Therapeutics Drug Sales by Regions 2.2.2 Global Psoriatic Arthritis Therapeutics Drug Revenue by Regions 3 Breakdown Data by Manufacturers 3.1 Psoriatic Arthritis Therapeutics Drug Sales by Manufacturers 3.1.1 Psoriatic Arthritis Therapeutics Drug Sales by Manufacturers 3.1.2 Psoriatic Arthritis Therapeutics Drug Sales Market Share by Manufacturers 3.1.3 Global Psoriatic Arthritis Therapeutics Drug Market Concentration Ratio (CR5 and HHI) 3.2 Psoriatic Arthritis Therapeutics Drug Revenue by Manufacturers 3.2.1 Psoriatic Arthritis Therapeutics Drug Revenue by Manufacturers (2014-2019) 3.2.2 Psoriatic Arthritis Therapeutics Drug Revenue Share by Manufacturers (2014-2019) 3.3 Psoriatic Arthritis Therapeutics Drug Price by Manufacturers 3.4 Psoriatic Arthritis Therapeutics Drug Manufacturing Base Distribution, Product Types 3.4.1 Psoriatic Arthritis Therapeutics Drug Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Psoriatic Arthritis Therapeutics Drug Product Type 3.4.3 Date of International Manufacturers Enter into Psoriatic Arthritis Therapeutics Drug Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Product 4.1 Global Psoriatic Arthritis Therapeutics Drug Sales by Product 4.2 Global Psoriatic Arthritis Therapeutics Drug Revenue by Product 4.3 Psoriatic Arthritis Therapeutics Drug Price by Product 5 Breakdown Data by End User 5.1 Overview 5.2 Global Psoriatic Arthritis Therapeutics Drug Breakdown Data by End User 6 North America 6.1 North America Psoriatic Arthritis Therapeutics Drug by Countries 6.1.1 North America Psoriatic Arthritis Therapeutics Drug Sales by Countries 6.1.2 North America Psoriatic Arthritis Therapeutics Drug Revenue by Countries 6.1.3 United States 6.1.4 Canada 6.1.5 Mexico 6.2 North America Psoriatic Arthritis Therapeutics Drug by Product 6.3 North America Psoriatic Arthritis Therapeutics Drug by End User 7 Europe 7.1 Europe Psoriatic Arthritis Therapeutics Drug by Countries 7.1.1 Europe Psoriatic Arthritis Therapeutics Drug Sales by Countries 7.1.2 Europe Psoriatic Arthritis Therapeutics Drug Revenue by Countries 7.1.3 Germany 7.1.4 France 7.1.5 UK 7.1.6 Italy 7.1.7 Russia 7.2 Europe Psoriatic Arthritis Therapeutics Drug by Product 7.3 Europe Psoriatic Arthritis Therapeutics Drug by End User 8 Asia Pacific 8.1 Asia Pacific Psoriatic Arthritis Therapeutics Drug by Countries 8.1.1 Asia Pacific Psoriatic Arthritis Therapeutics Drug Sales by Countries 8.1.2 Asia Pacific Psoriatic Arthritis Therapeutics Drug Revenue by Countries 8.1.3 China 8.1.4 Japan 8.1.5 Korea 8.1.6 India 8.1.7 Australia 8.1.8 Indonesia 8.1.9 Malaysia 8.1.10 Philippines 8.1.11 Thailand 8.1.12 Vietnam 8.1.13 Singapore 8.2 Asia Pacific Psoriatic Arthritis Therapeutics Drug by Product 8.3 Asia Pacific Psoriatic Arthritis Therapeutics Drug by End User 9 Central & South America 9.1 Central & South America Psoriatic Arthritis Therapeutics Drug by Countries 9.1.1 Central & South America Psoriatic Arthritis Therapeutics Drug Sales by Countries 9.1.2 Central & South America Psoriatic Arthritis Therapeutics Drug Revenue by Countries 9.1.3 Brazil 9.2 Central & South America Psoriatic Arthritis Therapeutics Drug by Product 9.3 Central & South America Psoriatic Arthritis Therapeutics Drug by End User 10 Middle East and Africa 10.1 Middle East and Africa Psoriatic Arthritis Therapeutics Drug by Countries 10.1.1 Middle East and Africa Psoriatic Arthritis Therapeutics Drug Sales by Countries 10.1.2 Middle East and Africa Psoriatic Arthritis Therapeutics Drug Revenue by Countries 10.1.3 GCC Countries 10.1.4 Turkey 10.1.5 Egypt 10.1.6 South Africa 10.2 Middle East and Africa Psoriatic Arthritis Therapeutics Drug by Product 10.3 Middle East and Africa Psoriatic Arthritis Therapeutics Drug by End User 11 Company Profiles 11.1 AbbVie 11.1.1 AbbVie Company Details 11.1.2 Company Business Overview 11.1.3 AbbVie Psoriatic Arthritis Therapeutics Drug Sales, Revenue and Gross Margin (2014-2019) 11.1.4 AbbVie Psoriatic Arthritis Therapeutics Drug Products Offered 11.1.5 AbbVie Recent Development 11.2 Janssen Biotech 11.2.1 Janssen Biotech Company Details 11.2.2 Company Business Overview 11.2.3 Janssen Biotech Psoriatic Arthritis Therapeutics Drug Sales, Revenue and Gross Margin (2014-2019) 11.2.4 Janssen Biotech Psoriatic Arthritis Therapeutics Drug Products Offered 11.2.5 Janssen Biotech Recent Development 11.3 Novartis 11.3.1 Novartis Company Details 11.3.2 Company Business Overview 11.3.3 Novartis Psoriatic Arthritis Therapeutics Drug Sales, Revenue and Gross Margin (2014-2019) 11.3.4 Novartis Psoriatic Arthritis Therapeutics Drug Products Offered 11.3.5 Novartis Recent Development 11.4 Amgen 11.4.1 Amgen Company Details 11.4.2 Company Business Overview 11.4.3 Amgen Psoriatic Arthritis Therapeutics Drug Sales, Revenue and Gross Margin (2014-2019) 11.4.4 Amgen Psoriatic Arthritis Therapeutics Drug Products Offered 11.4.5 Amgen Recent Development 11.5 CELGENE CORPORATION 11.5.1 CELGENE CORPORATION Company Details 11.5.2 Company Business Overview 11.5.3 CELGENE CORPORATION Psoriatic Arthritis Therapeutics Drug Sales, Revenue and Gross Margin (2014-2019) 11.5.4 CELGENE CORPORATION Psoriatic Arthritis Therapeutics Drug Products Offered 11.5.5 CELGENE CORPORATION Recent Development 11.6 Pfizer 11.6.1 Pfizer Company Details 11.6.2 Company Business Overview 11.6.3 Pfizer Psoriatic Arthritis Therapeutics Drug Sales, Revenue and Gross Margin (2014-2019) 11.6.4 Pfizer Psoriatic Arthritis Therapeutics Drug Products Offered 11.6.5 Pfizer Recent Development 11.7 Eli Lilly 11.7.1 Eli Lilly Company Details 11.7.2 Company Business Overview 11.7.3 Eli Lilly Psoriatic Arthritis Therapeutics Drug Sales, Revenue and Gross Margin (2014-2019) 11.7.4 Eli Lilly Psoriatic Arthritis Therapeutics Drug Products Offered 11.7.5 Eli Lilly Recent Development 11.8 UCB 11.8.1 UCB Company Details 11.8.2 Company Business Overview 11.8.3 UCB Psoriatic Arthritis Therapeutics Drug Sales, Revenue and Gross Margin (2014-2019) 11.8.4 UCB Psoriatic Arthritis Therapeutics Drug Products Offered 11.8.5 UCB Recent Development 11.9 Biogen 11.9.1 Biogen Company Details 11.9.2 Company Business Overview 11.9.3 Biogen Psoriatic Arthritis Therapeutics Drug Sales, Revenue and Gross Margin (2014-2019) 11.9.4 Biogen Psoriatic Arthritis Therapeutics Drug Products Offered 11.9.5 Biogen Recent Development 11.10 Bristol-Myers Squibb 11.10.1 Bristol-Myers Squibb Company Details 11.10.2 Company Business Overview 11.10.3 Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Drug Sales, Revenue and Gross Margin (2014-2019) 11.10.4 Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Drug Products Offered 11.10.5 Bristol-Myers Squibb Recent Development 12 Future Forecast 12.1 Psoriatic Arthritis Therapeutics Drug Market Forecast by Regions 12.1.1 Global Psoriatic Arthritis Therapeutics Drug Sales Forecast by Regions 2019-2025 12.1.2 Global Psoriatic Arthritis Therapeutics Drug Revenue Forecast by Regions 2019-2025 12.2 Psoriatic Arthritis Therapeutics Drug Market Forecast by Product 12.2.1 Global Psoriatic Arthritis Therapeutics Drug Sales Forecast by Product 2019-2025 12.2.2 Global Psoriatic Arthritis Therapeutics Drug Revenue Forecast by Product 2019-2025 12.3 Psoriatic Arthritis Therapeutics Drug Market Forecast by End User 12.4 North America Psoriatic Arthritis Therapeutics Drug Forecast 12.5 Europe Psoriatic Arthritis Therapeutics Drug Forecast 12.6 Asia Pacific Psoriatic Arthritis Therapeutics Drug Forecast 12.7 Central & South America Psoriatic Arthritis Therapeutics Drug Forecast 12.8 Middle East and Africa Psoriatic Arthritis Therapeutics Drug Forecast 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Macroscopic Indicators 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Psoriatic Arthritis Therapeutics Drug Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables and Figures Figure Psoriatic Arthritis Therapeutics Drug Product Picture Table Psoriatic Arthritis Therapeutics Drug Market Segments Table Key Manufacturers Psoriatic Arthritis Therapeutics Drug Covered Table Global Psoriatic Arthritis Therapeutics Drug Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$) Figure Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Product 2014-2025 Figure NF Inhibitors Product Picture Table Major Manufacturers of NF Inhibitors Figure Interleukin Inhibitors Product Picture Table Major Manufacturers of Interleukin Inhibitors Figure PDE4 Inhibitors Product Picture Table Major Manufacturers of PDE4 Inhibitors Figure Others Product Picture Table Major Manufacturers of Others Table Global Psoriatic Arthritis Therapeutics Drug Market Size Growth Rate by End User 2019-2025 (K Units) Figure Hospital Pharmacies Figure Retail Pharmacies Figure Online Pharmacies Figure Psoriatic Arthritis Therapeutics Drug Report Years Considered Figure Global Psoriatic Arthritis Therapeutics Drug Market Size 2014-2025 (Million US$) Figure Global Psoriatic Arthritis Therapeutics Drug Sales 2014-2025 (K Units) Table Global Psoriatic Arthritis Therapeutics Drug Market Size by Regions 2014-2019 (K Units) & (Million US$) Table Global Psoriatic Arthritis Therapeutics Drug Sales by Regions 2014-2019 (K Units) Table Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Regions 2014-2019 Figure Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Regions 2014-2019 Figure 2018 Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Regions Table Global Psoriatic Arthritis Therapeutics Drug Revenue by Regions 2014-2019 (Million US$) Table Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Regions 2014-2019 Figure Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Regions 2014-2019 Figure 2018 Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Regions Table Global Psoriatic Arthritis Therapeutics Drug Sales by Manufacturers (2014-2019) (K Units) Table Global Psoriatic Arthritis Therapeutics Drug Sales Share by Manufacturers (2014-2019) Figure Global Psoriatic Arthritis Therapeutics Drug Sales Share by Manufacturers in 2018 Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Psoriatic Arthritis Therapeutics Drug Revenue by Manufacturers (2014-2019) (Million USD) Table Psoriatic Arthritis Therapeutics Drug Revenue Share by Manufacturers (2014-2019) Figure Psoriatic Arthritis Therapeutics Drug Value Share by Manufacturers in 2018 Table Key Manufacturers Psoriatic Arthritis Therapeutics Drug Price (2014-2019) (USD/Unit) Table Psoriatic Arthritis Therapeutics Drug Manufacturers Manufacturing Base Distribution and Headquarters Table Manufacturers Psoriatic Arthritis Therapeutics Drug Product Type Table Date of International Manufacturers Enter into Psoriatic Arthritis Therapeutics Drug Market Table Manufacturers Mergers & Acquisitions, Expansion Plans Table Global Psoriatic Arthritis Therapeutics Drug Sales by Product (2014-2019) (K Units) Table Global Psoriatic Arthritis Therapeutics Drug Sales Share by Product (2014-2019) Figure Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Product (2014-2019) Figure Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Product in 2018 Table Global Psoriatic Arthritis Therapeutics Drug Revenue by Product (2014-2019) (Million US$) Table Global Psoriatic Arthritis Therapeutics Drug Revenue Share by Product (2014-2019) Figure Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Product (2014-2019) Figure Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Product in 2018 Table Psoriatic Arthritis Therapeutics Drug Price by Product 2014-2019 (USD/Unit) Table Global Psoriatic Arthritis Therapeutics Drug Sales by End User (2014-2019) (K Units) Table Global Psoriatic Arthritis Therapeutics Drug Sales Share by End User (2014-2019) Figure Global Sales Psoriatic Arthritis Therapeutics Drug Market Share by End User (2014-2019) Figure Global Sales Psoriatic Arthritis Therapeutics Drug Market Share by End User in 2018 Figure North America Psoriatic Arthritis Therapeutics Drug Sales Growth Rate 2014-2019 (K Units) Figure North America Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate 2014-2019 (Million US$) Table North America Psoriatic Arthritis Therapeutics Drug Sales by Countries (2014-2019) (K Units) Table North America Psoriatic Arthritis Therapeutics Drug Sales Market Share by Countries (2014-2019) Figure 2018 North America Psoriatic Arthritis Therapeutics Drug Sales Market Share by Countries Table North America Psoriatic Arthritis Therapeutics Drug Revenue by Countries (2014-2019) (Million US$) Table North America Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Countries (2014-2019) Figure 2018 North America Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Countries Figure United States Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2014-2019) (K Units) Figure United States Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2014-2019) (K Units) Figure Canada Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2014-2019) (K Units) Figure Canada Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Mexico Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2014-2019) (K Units) Figure Mexico Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2014-2019) (Million US$) Table North America Psoriatic Arthritis Therapeutics Drug Sales by Product (2014-2019) (K Units) Table North America Psoriatic Arthritis Therapeutics Drug Sales Market Share by Product (2014-2019) Figure 2018 North America Psoriatic Arthritis Therapeutics Drug Market Share by Product Table North America Psoriatic Arthritis Therapeutics Drug Sales by End User (2014-2019) (K Units) Table North America Psoriatic Arthritis Therapeutics Drug Sales Market Share by End User (2014-2019) Figure 2018 North America Psoriatic Arthritis Therapeutics Drug Market Share by End User Figure Europe Psoriatic Arthritis Therapeutics Drug Sales Growth Rate 2014-2019 (K Units) Figure Europe Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate 2014-2019 (Million US$) Table Europe Psoriatic Arthritis Therapeutics Drug Sales by Countries (2014-2019) (K Units) Table Europe Psoriatic Arthritis Therapeutics Drug Sales Market Share by Countries (2014-2019) Figure 2018 Europe Psoriatic Arthritis Therapeutics Drug Sales Market Share by Countries Table Europe Psoriatic Arthritis Therapeutics Drug Revenue by Countries (2014-2019) (Million US$) Table Europe Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Countries (2014-2019) Figure 2018 Europe Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Countries Figure Germany Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2014-2019) (K Units) Figure Germany Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2014-2019) (Million US$) Figure France Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2014-2019) (K Units) Figure France Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2014-2019) (Million US$) Figure UK Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2014-2019) (K Units) Figure UK Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Italy Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2014-2019) (K Units) Figure Italy Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Russia Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2014-2019) (K Units) Figure Russia Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2014-2019) (Million US$) Table Europe Psoriatic Arthritis Therapeutics Drug Sales by Product (2014-2019) (K Units) Table Europe Psoriatic Arthritis Therapeutics Drug Sales Market Share by Product (2014-2019) Figure 2018 Europe Psoriatic Arthritis Therapeutics Drug Market Share by Product Table Europe Psoriatic Arthritis Therapeutics Drug Sales by End User (2014-2019) (K Units) Table Europe Psoriatic Arthritis Therapeutics Drug Sales Market Share by End User (2014-2019) Figure 2018 Europe Psoriatic Arthritis Therapeutics Drug Market Share by End User Figure Asia Pacific Psoriatic Arthritis Therapeutics Drug Sales Growth Rate 2014-2019 (K Units) Figure Asia Pacific Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate 2014-2019 (Million US$) Table Asia Pacific Psoriatic Arthritis Therapeutics Drug Sales by Countries (2014-2019) (K Units) Table Asia Pacific Psoriatic Arthritis Therapeutics Drug Sales Market Share by Countries (2014-2019) Figure 2018 Asia Pacific Psoriatic Arthritis Therapeutics Drug Sales Market Share by Countries Table Asia Pacific Psoriatic Arthritis Therapeutics Drug Revenue by Countries (2014-2019) (Million US$) Table Asia Pacific Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Countries (2014-2019) Figure 2018 Asia Pacific Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Countries Figure China Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2014-2019) (K Units) Figure China Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Japan Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2014-2019) (K Units) Figure Japan Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Korea Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2014-2019) (K Units) Figure Korea Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2014-2019) (Million US$) Figure India Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2014-2019) (K Units) Figure India Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Australia Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2014-2019) (K Units) Figure Australia Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Indonesia Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2014-2019) (K Units) Figure Indonesia Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Malaysia Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2014-2019) (K Units) Figure Malaysia Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Philippines Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2014-2019) (K Units) Figure Philippines Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Thailand Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2014-2019) (K Units) Figure Thailand Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Vietnam Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2014-2019) (K Units) Figure Vietnam Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Singapore Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2014-2019) (K Units) Figure Singapore Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2014-2019) (Million US$) Table Asia Pacific Psoriatic Arthritis Therapeutics Drug Sales by Product (2014-2019) (K Units) Table Asia Pacific Psoriatic Arthritis Therapeutics Drug Sales Market Share by Product (2014-2019) Figure 2018 Asia Pacific Psoriatic Arthritis Therapeutics Drug Market Share by Product Table Asia Pacific Psoriatic Arthritis Therapeutics Drug Sales by End User (2014-2019) (K Units) Table Asia Pacific Psoriatic Arthritis Therapeutics Drug Sales Market Share by End User (2014-2019) Figure 2018 Asia Pacific Psoriatic Arthritis Therapeutics Drug Market Share by End User Figure Central & South America Psoriatic Arthritis Therapeutics Drug Sales Growth Rate 2014-2019 (K Units) Figure Central & South America Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate 2014-2019 (Million US$) Table Central & South America Psoriatic Arthritis Therapeutics Drug Sales by Countries (2014-2019) (K Units) Table Central & South America Psoriatic Arthritis Therapeutics Drug Sales Market Share by Countries (2014-2019) Figure 2018 Central & South America Psoriatic Arthritis Therapeutics Drug Sales Market Share by Countries Table Central & South America Psoriatic Arthritis Therapeutics Drug Revenue by Countries (2014-2019) (Million US$) Table Central & South America Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Countries (2014-2019) Figure 2018 Central & South America Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Countries Figure Brazil Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2014-2019) (K Units) Figure Brazil Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Argentina Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2014-2019) (K Units) Figure Argentina Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2014-2019) (Million US$) Table Central & South America Psoriatic Arthritis Therapeutics Drug Sales by Product (2014-2019) (K Units) Table Central & South America Psoriatic Arthritis Therapeutics Drug Sales Market Share by Product (2014-2019) Figure 2018 Central & South America Psoriatic Arthritis Therapeutics Drug Market Share by Product Table Central & South America Psoriatic Arthritis Therapeutics Drug Sales by End User (2014-2019) (K Units) Table Central & South America Psoriatic Arthritis Therapeutics Drug Sales Market Share by End User (2014-2019) Figure 2018 Central & South America Psoriatic Arthritis Therapeutics Drug Market Share by End User Figure Middle East and Africa Psoriatic Arthritis Therapeutics Drug Sales Growth Rate 2014-2019 (K Units) Figure Middle East and Africa Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate 2014-2019 (Million US$) Table Middle East and Africa Psoriatic Arthritis Therapeutics Drug Sales by Countries (2014-2019) (K Units) Table Middle East and Africa Psoriatic Arthritis Therapeutics Drug Sales Market Share by Countries (2014-2019) Figure 2018 Middle East and Africa Psoriatic Arthritis Therapeutics Drug Sales Market Share by Countries Table Middle East and Africa Psoriatic Arthritis Therapeutics Drug Revenue by Countries (2014-2019) (Million US$) Table Middle East and Africa Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Countries (2014-2019) Figure 2018 Middle East and Africa Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Countries Figure GCC Countries Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2014-2019) (K Units) Figure GCC Countries Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Turkey Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2014-2019) (K Units) Figure Turkey Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2014-2019) (Million US$) Figure Egypt Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2014-2019) (K Units) Figure Egypt Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2014-2019) (Million US$) Figure South Africa Psoriatic Arthritis Therapeutics Drug Sales Growth Rate (2014-2019) (K Units) Figure South Africa Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate (2014-2019) (Million US$) Table Middle East and Africa Psoriatic Arthritis Therapeutics Drug Sales by Product (2014-2019) (K Units) Table Middle East and Africa Psoriatic Arthritis Therapeutics Drug Sales Market Share by Product (2014-2019) Figure 2018 Middle East and Africa Psoriatic Arthritis Therapeutics Drug Market Share by Product Table Middle East and Africa Psoriatic Arthritis Therapeutics Drug Sales by End User (2014-2019) (K Units) Table Middle East and Africa Psoriatic Arthritis Therapeutics Drug Sales Market Share by End User (2014-2019) Figure 2018 Middle East and Africa Psoriatic Arthritis Therapeutics Drug Market Share by End User Table AbbVie Company Details Table AbbVie Psoriatic Arthritis Therapeutics Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table AbbVie Recent Development Table Janssen Biotech Company Details Table Janssen Biotech Psoriatic Arthritis Therapeutics Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Janssen Biotech Recent Development Table Novartis Company Details Table Novartis Psoriatic Arthritis Therapeutics Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Novartis Recent Development Table Amgen Company Details Table Amgen Psoriatic Arthritis Therapeutics Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Amgen Recent Development Table CELGENE CORPORATION Company Details Table CELGENE CORPORATION Psoriatic Arthritis Therapeutics Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table CELGENE CORPORATION Recent Development Table Pfizer Company Details Table Pfizer Psoriatic Arthritis Therapeutics Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Pfizer Recent Development Table Eli Lilly Company Details Table Eli Lilly Psoriatic Arthritis Therapeutics Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Eli Lilly Recent Development Table UCB Company Details Table UCB Psoriatic Arthritis Therapeutics Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table UCB Recent Development Table Biogen Company Details Table Biogen Psoriatic Arthritis Therapeutics Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Biogen Recent Development Table Bristol-Myers Squibb Company Details Table Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Bristol-Myers Squibb Recent Development Table Global Psoriatic Arthritis Therapeutics Drug Sales Forecast by Regions 2019-2025 (K Units) Table Global Psoriatic Arthritis Therapeutics Drug Sales Market Share Forecast by Regions 2019-2025 Table Global Psoriatic Arthritis Therapeutics Drug Revenue Forecast by Regions 2019-2025 (Million US$) Table Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share Forecast by Regions 2019-2025 Table Global Psoriatic Arthritis Therapeutics Drug Sales Forecast by Product 2019-2025 (K Units) Table Global Psoriatic Arthritis Therapeutics Drug Sales Market Share Forecast by Product 2019-2025 Table Global Psoriatic Arthritis Therapeutics Drug Revenue Forecast by Product 2019-2025 (Million US$) Table Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share Forecast by Product 2019-2025 Table Global Psoriatic Arthritis Therapeutics Drug Sales Forecast by End User 2019-2025 (K Units) Table Global Psoriatic Arthritis Therapeutics Drug Sales Market Share Forecast by End User 2019-2025 Figure North America Psoriatic Arthritis Therapeutics Drug Sales Growth Rate Forecast (2019-2025) (K Units) Figure North America Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Europe Psoriatic Arthritis Therapeutics Drug Sales Growth Rate Forecast (2019-2025) (K Units) Figure Europe Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Asia Pacific Psoriatic Arthritis Therapeutics Drug Sales Growth Rate Forecast (2019-2025) (K Units) Figure Asia Pacific Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Central & South America Psoriatic Arthritis Therapeutics Drug Sales Growth Rate Forecast (2019-2025) (K Units) Figure Central & South America Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Middle East and Africa Psoriatic Arthritis Therapeutics Drug Sales Growth Rate Forecast (2019-2025) (K Units) Figure Middle East and Africa Psoriatic Arthritis Therapeutics Drug Revenue Growth Rate Forecast (2019-2025) (Million US$) Table Psoriatic Arthritis Therapeutics Drug Value Chain Table Psoriatic Arthritis Therapeutics Drug Customers List Table Psoriatic Arthritis Therapeutics Drug Distributors List Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

AbbVie Janssen Biotech Novartis Amgen CELGENE CORPORATION Pfizer Eli Lilly UCB Biogen Bristol-Myers Squibb